CM
MDT icon

Crestline Management’s Medtronic MDT Stock Holding History

Crestline Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,486
Closed -$678K – 379
2024
Q4 		$678K Sell
8,486
-13,175
-61% -$1.14M 0.02% 490
2024
Q3 		$1.95M Buy
+21,661
New +$1.82M 0.1% 191
2016
Q4 		– Sell
-17,858
Closed -$1.54M – 152
2016
Q3 		$1.54M Buy
+17,858
New +$1.56M 0.2% 57

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Crestline Management's MDT Position: Q1 2025 in Review

Crestline Management sold out of Medtronic (MDT) in Q1 2025, closing a stake of 8,486 shares — an estimated $678K sold.

Crestline Management first reported a position in MDT in Q3 2016 and held it in 3 quarters. The position peaked at $1.95M in Q3 2024. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Crestline Management reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 8,486 Medtronic shares in Q1 2025, an estimated $678K.
  • Crestline Management first reported a position in Medtronic in Q3 2016 and held it in 3 quarters.
  • Crestline Management's Medtronic position peaked at $1.95M in Q3 2024.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.